VRTX
#112
Vertex Pharmaceuticals Incorporated - Common Stock
541.6 9 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.07%
Changement Mensuel
+14.26%
Evolution sur 6 mois
+9.29%
Changement Annuel
+38.53%
Clôture Précédente
547.5 5
Open
541.6 9
Low
541.6 9
High
541.6 9
Volume
298
Financials
- Market Capitalization 137.3 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
29.59
ratio cours/chiffre d'affaires
9.75
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 208 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 794.19 USD | -1.67% | -4.83% | +13.46% | +36.80% | 81.77 B USD | ||
| 263 |  ARGX argenx SE - American Depositary Shares | 1023.21 USD | -3.37% | -0.01% | +18.84% | +43.71% | 63.32 B USD | ||
| 296 |  MRNA Moderna, Inc. - Common Stock | 137.99 USD | -3.35% | -3.30% | +146.94% | +476.64% | 55.09 B USD | ||
| 351 |  RVMD Revolution Medicines, Inc. - Common Stock | 207.88 USD | -6.00% | -0.57% | +13.25% | +275.23% | 44.56 B USD |